Background
==========

The conserved family of homeodomain Hox transcription factors is critically involved in patterning the body plan of bilaterian embryos by controlling multiple morphogenetic and organogenetic processes during animal development \[[@B1]-[@B4]\]. Modifications in Hox protein expression and activity have likely contributed to the evolutionary diversification of animal forms \[[@B5],[@B6]\]. Misregulation or mutation of several Hox proteins has been associated with pathologies like cancer or neuropathies \[[@B7],[@B8]\].

Hox proteins are transcription factors which regulate expression of target genes and chromatin remodeling \[[@B9]\]. A handful of proteins that interact with Hox proteins have been identified so far, and these are almost exclusively transcription factors, like the well-characterized Three Amino acid Loop Extension (TALE) homeodomain proteins Pbx/Exd and Prep/Meis/Hth \[[@B10]\], TFIIE*β*\[[@B11]\], TATA Binding Protein (TBP) \[[@B12]\], Gli3 \[[@B13]\], Maf \[[@B14]\], Smad \[[@B15],[@B16]\], High Mobility Group protein 1 (HMG1) \[[@B17]\], or transcriptional coregulators like CREB Binding Protein (CBP)/p300 \[[@B18]-[@B20]\]. Hox proteins may also form complexes with the translation initiation factor eIF4E to control the translation of target mRNAs \[[@B21]\]. Some Hox-like homeodomain proteins can be secreted into the extracellular compartment and translocate through the cell membrane to gain access to the cytosol and nucleus of neighboring cells, so it has been proposed that Hox proteins could display a paracrine transcriptional activity \[[@B22],[@B23]\].

Numerous transcription factors, involved in critical developmental processes, like Smad, STAT, β-catenin or NFκB, are primarily signal transducers. Though primarily cytoplasmic, upon activation these can translocate to the nucleus, where they convey signaling by affecting gene regulation. As signal transducers these transcription factors can interact with enzymatically active membrane receptors, adaptor proteins, signal transducing kinases, or ubitiquin ligases. Possibly, Hox transcription factors could similarly fulfill pivotal roles at the heart of developmental processes, acting at the crossroads between cell-to-cell communication and cell fate determination. To our knowledge no exhaustive interaction screen has been performed to detect functional connections for a Hox protein.

Here, we conducted a proteome-wide screening for candidate interactors of Hoxa1. *Hoxa1* is one of the earliest *Hox* genes to be expressed during embryonic development. It is involved in hindbrain segmentation and patterning \[[@B1],[@B24],[@B25]\]. *Hoxa1* misregulation has been associated with mammary carcinogenesis \[[@B26]\]. We used a stringent high-throughput yeast two-hybrid (Y2H) approach to systematically test pairwise combinations, using Hoxa1 both as a bait and as a prey against the human ORFeome v3.1 resource, which contains 12,212 ORFs representing 10,214 genes \[[@B27]\]. Of the 59 Hoxa1 interactions identified, 45 could be validated by *in vivo* affinity binding assays in co-transfected animal cells. A striking subset of the validated interactors are not proteins involved in gene regulation. Rather, these interactors are adaptor proteins or modulators of the Bone Morphogenetic Proteins (BMP)/Tumor Growth Factor (TGF) β, Tumor Necrosis Factor (TNF), Receptor-Tyrosine Kinases (RTK) and integrins signal transduction pathways. Other interactors participate in cell adhesion or endosomal trafficking. We detected 41 interactions in live cells by Bimolecular Fluorescence Complementation (BiFC). Depending on the different proteins identified, interactions either take place in the cytoplasm, in the nucleus, in association with vesicles or show a variable pattern from cell to cell, underscoring a dynamic interplay with Hoxa1. Numerous identified Hoxa1 partners reported to interact with each other within known pathways share similar intracellular patterns of Hoxa1 interaction by BiFC. We conclude that Hoxa1 can contact several subunits of multi-molecular functional platforms involved in cell signaling, cell-adhesion, or cell shape regulation.

Results
=======

A proteome-wide yeast two-hybrid screening for Hoxa1 interactors
----------------------------------------------------------------

The yeast two-hybrid (Y2H) is a powerful approach for large-scale screenings to identify binary protein-protein interactions \[[@B28],[@B29]\]. DB-Hoxa1 was tested pairwise against 12,212 open reading frame (ORF)-derived proteins from the human ORFeome version 3.1 \[[@B27]\] fused to the Gal4 activation domain (AD). In this configuration, we detected 40 distinct interactions (Table [1](#T1){ref-type="table"}). We also screened in the other configuration, Hoxa1 as a prey (AD-Hoxa1) against the full hORFeome in fusion with the Gal4 DB. In the second configuration we detected 28 interactions, of which 8 were also detected in the DB-Hoxa1/AD-ORFs configuration (Table [2](#T2){ref-type="table"}). A total of 59 candidate Hoxa1 interactors were identified. We found the Hoxa1 homodimerization interaction and 8 out of the 9 Hoxa1 interactions, previously described in the literature \[[@B28],[@B30]\] (Table [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}).

###### 

Interaction partners for Hoxa1 revealed by yeast two-hybrid screening using DB-Hoxa1

  **Protein symbol**   **Protein name**                                                                   **Gene ID**   **UniProtKB/Swiss-Prot**   **Protein function**                                                                                               **BiFC signal**                   **Confirmed by co-purification**
  -------------------- ---------------------------------------------------------------------------------- ------------- -------------------------- ------------------------------------------------------------------------------------------------------------------ --------------------------------- ----------------------------------
  ADAMTSL4 (TSRC1)     ADAMTS-like 4                                                                      54507         Q6UY14                     TNF-induced apopotosis                                                                                             Nuclear                           Y
  BAT2L                HLA-B associated transcript 2-like                                                 84726         Q5JSZ5                     Unknown                                                                                                            Nuclear                           Y
  C1orf94              chromosome 1 open reading frame 94                                                 84970         Q6P1W5                     Protein binding                                                                                                    Cytoplasmic                       Y
  CCDC33               coiled-coil domain containing 33                                                   80125         Q8N5R6                     Protein binding                                                                                                    /                                 N
  EFCAB4B              EF-hand calcium binding domain 4B                                                  84766         Q9BSW2                     Calcium binding                                                                                                    Nuclear, and vesicular            Y
  EFEMP2\*^§^          EGF-containing fibulin-like extracellular matrix protein 2                         30008         O95967                     Fibulin-like, unknown                                                                                              n.d.                              Y
  FAM154A              family with sequence similarity 154, member A                                      158297        Q8IYX7                     Unknown                                                                                                            Nuclear, vesicular, cytoplasmic   Y
  FHL5 (ACT)           four and a half LIM domains 5                                                      9457          Q5TD97                     Transcription factor (zinc finger), and kinesin and actin-binding protein                                          Nuclear                           Y
  GPRIN2               G protein regulated inducer of neurite outgrowth 2                                 9721          O60269                     G protein interaction                                                                                              /                                 N
  HOXA1^§^             homeobox A1                                                                        3198          P49639                     Transcription factor (homeodomain)                                                                                 Nuclear                           Y
  HOXD3                homeobox D3                                                                        3232          P31249                     Transcription factor (homeodomain)                                                                                 Nuclear                           Y
  HSFY1                heat shock transcription factor, Y-linked 1                                        86614         Q96LI6                     Transcription factor (heatshock factor)                                                                            /                                 N
  KRTAP26-1^§^         keratin associated protein 26-1                                                    388818        Q6PEX3                     Keratin associated                                                                                                 Nuclear                           Y
  KRTAP3-2^§^          keratin associated protein 3-2                                                     83897         Q9BYR7                     Keratin associated                                                                                                 Nuclear                           Y
  KRTAP3-3^§^          keratin associated protein 3-3                                                     85293         Q9BYR6                     Keratin associated                                                                                                 /                                 N
  KRTAP4-12\*^§^       keratin associated protein 4-12                                                    83755         Q9BQ66                     Keratin associated                                                                                                 Cytoplasmic                       Y
  LGALS13              lectin, galactoside-binding, soluble, 13                                           29124         Q9UHV8                     Lipase activity, signaling (regulator of protein kinases)                                                          Nuclear, vesicular, cytoplasmic   Y
  LNX2                 ligand of numb-protein X 2                                                         222484        Q8N448                     Molecular scaffold, E3 ubiquitin ligase, signaling regulator (Notch), associated to cell adhesion molecules        Nuclear and cytoplasmic           Y
  LPXN\*               leupaxin                                                                           9404          O60711                     Signaling (focal adhesion), Transcription factor                                                                   Vesicular and cytoplasmic         Y
  MGAT5B (GnT-VB)      mannosyl (α-1,6-)-glycoprotein β-1,6-N-acetyl-glucosaminyltransferase, isozyme B   146664        Q3V5L5                     Glycosyltransferase, focal adhesion dynamics                                                                       Nuclear                           Y
  N4BP2L2 (PFAAP5)     NEDD4 binding protein 2-like 2                                                     10443         Q92802                     Transcription factor or co-regulator                                                                               Nuclear                           Y
  NR4A1 (Nur77)        nuclear receptor subfamily 4, group A, member 1                                    3164          P22736                     Transcription factor (nuclear hormone receptor)                                                                    /                                 N
  OGT                  O-linked N-acetylglucosamine (GlcNAc) transferase                                  8473          O15294                     Glycosyltransferase, transcription co-regulator                                                                    Nuclear and cytoplasmic           Y
  PCSK5^§^             proprotein convertase subtilisin/kexin type 5                                      5125          Q92824                     Pro-protein convertase                                                                                             /                                 N
  PDLIM7 (LMP-1)       PDZ and LIM domain 7                                                               9260          Q9NR12                     Signaling regulator (BMP, IGFBP pathways)                                                                          Cytoplasmic                       Y
  PLSCR1\*             phospholipid scramblase 1                                                          5359          O15162                     Phospholipid scramblase, signaling regulatior (receptor tyrosine kinases, protein kinases), transcription factor   Nuclear                           Y
  PLSCR4^§^            phospholipid scramblase 4                                                          57088         Q9NRQ2                     Phospholipid scramblase, transcription factor                                                                      Nuclear                           Y
  PRDM14               PR domain containing 14                                                            63978         Q9G2V8                     Histone methyltransferase                                                                                          Nuclear, vesicular, cytoplasmic   Y
  RBCK1                RanBP-type and C3HC4-type zinc finger containing 1                                 10616         Q9BYM8                     Signaling regulator (TNFR, protein kinases), ubiquitin ligase, transcription factor                                Nuclear, vesicular, cytoplasmic   Y
  RBPMS (Hermes)       RNA binding protein with multiple splicing                                         11030         Q93062                     Signaling regulator (TGFβ), RNA binding                                                                            Nuclear, vesicular, cytoplasmic   Y
  RGS17                regulator of G-protein signaling 17                                                26575         Q9UGC6                     Signaling regulator (G proteins)                                                                                   /                                 N
  RGS20                regulator of G-protein signaling 20                                                8601          O76081                     Signaling regulator (G proteins, protein kinases)                                                                  Nuclear and cytoplasmic           Y
  SPRY1                sprouty homolog 1                                                                  10252         O43609                     Signaling regulator (receptor tyrosine kinases)                                                                    Nuclear, vesicular, cytoplasmic   Y
  SPRY2                sprouty homolog 2                                                                  10253         O43597                     Signaling regulator (receptor tyrosine kinases, protein kinases)                                                   /                                 N
  TRAF1                TNF receptor-associated factor 1                                                   7185          Q13077                     Signaling regulator (TNFR pathway)                                                                                 Vesicular and cytoplasmic         Y
  TRAF2                TNF receptor-associated factor 2                                                   7186          Q12933                     Signaling regulator (TNFR pathway)                                                                                 Vesicular and cytoplasmic         Y
  TRIM23 (ARD1)        tripartite motif-containing 23                                                     373           P36406                     Vesicular trafficking and signaling regulator (TNF pathway), E3 ubiquitin ligase                                   n.d.                              Y
  TRIP6\*              thyroid hormone receptor interactor 6                                              7205          Q15654                     Cytoskeleton and signaling regulator (focal adhesion, TNFR), transcription co-regulator                            Nuclear                           Y
  ZBTB16 (PLZF)        zinc finger and BTB domain containing 16                                           7704          Q05516                     Transcription factor (zinc finger), signaling regulator (GPCR, ProRenin Receptor)                                  Nuclear and vesicular             Y
  ZBTB32 (FAZF)        zinc finger and BTB domain containing 32                                           27033         Q9Y2Y4                     Transcription factor (zinc finger)                                                                                 Cytoplasmic                       Y

\* Previously reported by Rual et al., 2005.

^§^ Revealed by both AD-ORF and DB-ORF screening.

^*a*^ Y = yes; N = no.

###### 

Interaction partners for Hoxa1 revealed by Y2H screening using AD-Hoxa1

  **Protein symbol**   **Protein name**                                                            **Gene ID**   **UniProtKB/Swiss-Prot**   **Protein function**                                                                                                             **BiFC signal**                   **Confirmed by co-purification**
  -------------------- --------------------------------------------------------------------------- ------------- -------------------------- -------------------------------------------------------------------------------------------------------------------------------- --------------------------------- ----------------------------------
  ADCK4                aarF domain containing kinase 4                                             79934         Q96D53                     Ser/Thr kinase                                                                                                                   /                                 N
  AGPAT1               1-acylglycerol-3-phosphate O-acyltransferase 1                              10554         Q99943                     Acetyltransferase                                                                                                                /                                 N
  BSCL2 (Seipin)       Berardinelli-Seip congenital lipodystrophy 2                                26580         Q96G97                     Unknown                                                                                                                          /                                 N
  DKKL1 (Soggy)        dickkopf-like 1                                                             27120         Q9UK85                     Signaling modulator (Wnt pathway)                                                                                                /                                 N
  EFEMP2\*^§^          EGF-containing fibulin-like extracellular matrix protein 2                  30008         O95967                     Fibulin-like, unknown                                                                                                            n.d.                              Y
  FAM108A1             family with sequence similarity 108, member A1                              81926         Q96GS6                     unknown                                                                                                                          Nuclear                           Y
  GP9                  glycoprotein IX (platelet)                                                  2815          P14770                     Multifunctional receptor, cytoskeleton and signaling regulator (integrins, focal adhesion, PI3K)                                 /                                 N
  GRN\*                granulin                                                                    2896          P28799                     Growth factor, transcription factor (in GRN precursor form)                                                                      n.d.                              Y
  HOXA1^§^             homeobox A1                                                                 3198          P49639                     Transcription factor (homeodomain)                                                                                               Nuclear                           Y
  HSD3B7               hydroxy-delta-5-steroid dehydrogenase, 3 β- and steroid delta-isomerase 7   80270         Q9H2F3                     Dehydrogenase                                                                                                                    /                                 N
  IKZF2 (Helios)       IKAROS family zinc finger 2                                                 22807         Q9UKS7                     Transcription fator (zinc finger)                                                                                                Nuclear                           Y
  KRT81                keratin 81                                                                  3887          Q14533                     Intermediate filament                                                                                                            Nuclear and cytoplasmic           Y
  KRTAP26-1^§^         keratin associated protein 26-1                                             388818        Q6PEX3                     Keratin associated                                                                                                               Nuclear                           Y
  KRTAP3-2^§^          keratin associated protein 3-2                                              83897         Q9BYR7                     Keratin associated                                                                                                               Nuclear                           Y
  KRTAP3-3^§^          keratin associated protein 3-3                                              85293         Q9BYR6                     Keratin associated                                                                                                               /                                 N
  KRTAP4-12\*^§^       keratin associated protein 4-12                                             83755         Q9BQ66                     Keratin associated                                                                                                               Cytoplasmic                       Y
  KRTAP5-9             keratin associated protein 5-9                                              3846          P26371                     Keratin associated                                                                                                               Vesicular and cytoplasmic         Y
  LIMS1 (PINCH1)       LIM and senescent cell antigen-like domains 1                               3987          P48059                     Cytoskeleton and signaling regulator (focal adhesion, integrins, receptor tyrosine kinases)                                      Nuclear                           Y
  MDFI\* (I-mfa)       MyoD family inhibitor                                                       4188          Q99750                     Signaling regulator (channels, Wnt, JNK pathways) - Transcription factor (I-mfa domain),                                         Nuclear, vesicular, cytoplasmic   Y
  PCSK5^§^             proprotein convertase subtilisin/kexin type 5                               5125          Q92824                     Pro-protein convertase                                                                                                           /                                 N
  PDCD6IP (Alix)       programmed cell death 6 interacting protein                                 10015         Q8WUM4                     Endosome formation and vesicular trafficking, cytoskeleton and signaling regulator (Focal adhesion, TNFR pathway, EGFR, PDGFR)   Vesicular and cytoplasmic         Y
  PFKM                 phosphofructokinase, muscle                                                 5213          P08237                     Glycolysis                                                                                                                       /                                 N
  PITX2                paired-like homeodomain 2                                                   5308          Q99697                     Transcription factor (homeodomain)                                                                                               Nuclear                           Y
  PLSCR4^§^            phospholipid scramblase 4                                                   57088         Q9NRQ2                     Phospholipid scramblase, transcription factor                                                                                    Nuclear                           Y
  RAB33A               member RAS oncogene family                                                  9363          Q14088                     Small GTPase, vesicular trafficking (Ras pathway)                                                                                Nuclear                           Y
  SMOC1                SPARC related modular calcium binding 1                                     64093         Q9H4F8                     Extracellular matrix protein, signaling, migration and differentiation modulator                                                 n.d.                              Y
  TRAPPC6A\*           trafficking protein particle complex 6A                                     79090         O75865                     Vesicular trafficking                                                                                                            Nuclear                           Y
  ZZZ3                 zinc finger, ZZ-type containing 3                                           26009         Q8IYH5                     Transcription factor (zinc finger)                                                                                               Nuclear                           Y

\* Previously reported by Rual et al., 2005.

^§^ Revealed by both AD-ORF and DB-ORF screening.

^*a*^ Y = yes; N = no.

Co-purification from animal cells validate forty-five Hoxa1 interactors
-----------------------------------------------------------------------

To validate the 59 interactions identified by the Y2H screen by an orthogonal assay we turned to affinity co-purification of a FLAG-Hoxa1 fusion protein co-expressed with glutathione S-transferase (GST)-tagged candidate interactors in transfected COS7 or HEK293T cells. In absence of GST-partners, there was no or very weak background binding of FLAG-Hoxa1 onto the glutathione-agarose beads (Figure [1](#F1){ref-type="fig"}). As positive controls we measured Hoxa1 dimer formation \[[@B30],[@B31]\] and the reproducible interaction between Hoxa1 and Pbx1a \[[@B32]\] (Figure [1](#F1){ref-type="fig"}). In total, affinity co-purification from co-transfected cells confirmed 45 out of the 59 Y2H interactors (Table [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}), in the presence of which a detectable amount of FLAG-Hoxa1 remained associated to the GST-fusion/glutathione-agarose beads and could be detected on western blots. It should be noted however that some interactions could not be confirmed because the corresponding GST-ORF fusion was expressed at an undetectable level, if at all (data not shown).

![**Validation of 45 out of the 59 interactions revealed for Hoxa1 by affinity co-purification on glutathione-agarose beads.** Candidate interactors were fused with a GST-tag and co-expressed in transfected cells with a FLAG-Hoxa1 fusion protein. Western blots were run to detect FLAG-Hoxa1 from cell extracts before (Input) or after (Co-P) purification. The Hoxa1-Hoxa1 or PBX1A-Hoxa1 interactions were used as positive controls (see lanes with arrowheads). Negative control corresponds to transfected cells with the only FLAG-Hoxa1 fusion protein (C-, lanes with blue arrows). Some interactors which could not be confirmed by co-purification are also shown (red asterisks).](1471-213X-12-29-1){#F1}

Bioinformatics functional analysis
----------------------------------

To determine if Hoxa1 preferentially targets particular biological functions or pathways, we tested for statistical enrichment in regards to the Gene Ontology GO \[[@B33]\]), Kyoto Encyclopedia of Genes and Genomes KEGG; \[[@B34]\]) and Pathway Commons databases (<http://www.pathwaycommons.org>).

We observed that six GO terms were significantly overrepresented (Table [3](#T3){ref-type="table"}). These enriched annotations are consistent with known functions of Hoxa1, linking our set of interactors to developmental and transcription factor function. There were several additional enriched, though not statistically so, GO terms linked to development and transcription factors (Table [3](#T3){ref-type="table"}).

###### 

Gene Ontology (GO) enrichment analysis

  **GO term**                                                   **Obs\***   **Odds ratio**^**\$**^   **P-value**^**£**^   **Corr P-value**^**μ**^
  ------------------------------------------------------------- ----------- ------------------------ -------------------- -------------------------
  keratin filament                                              6           102,352                  3,62292E-10          1,19194E-07
  pattern specification process                                 6           12,3435                  2,01548E-05          0,00331547
  regionalization                                               5           14,3981                  0,000048482          0,00531685
  cranial nerve morphogenesis                                   2           116,248                  0,000331888          0,0272978
  kidney development                                            3           21,403                   0,000559756          0,0306933
  zinc ion binding                                              16          2,99882                  0,000514454          0,0338511
  embryonic development                                         6           5,58735                  0,00120012           0,0564059
  receptor signaling protein serine/threonine kinase activity   4           8,11769                  0,00208634           0,0624006
  developmental process                                         20          2,38882                  0,00204634           0,0673246
  negative regulation of MAP kinase activity                    2           19,4953                  0,00596027           0,0676182
  regulation of transcription factor import into nucleus        2           31,8952                  0,00251195           0,0688694
  cation binding                                                19          2,14904                  0,00649842           0,071266
  anterior/posterior pattern formation                          3           13,3725                  0,00198155           0,0724365
  cytoskeletal part                                             8           3,92527                  0,00191605           0,0787977
  inner ear morphogenesis                                       2           27,0115                  0,00335617           0,0788701

\* number of Hoxa1 interactors annotated with the corresponding GO term.

^\$^ the odds ratio represents the enrichment of the corresponding GO term in the set of Hoxa1 interaction partners, an odds ratio of 10 meaning that the considered GO term is observed 10 times more than expected at random.

^£^ probability to see at least the number of proteins corresponding to the GO term at random.

^μ^P-value including a correction for multiple testing.

The immediate interactors of Hoxa1 were not enriched for annotated pathways, which could be due to incomplete coverage or relative sensitivity of the Y2H assay \[[@B35]\], or be intrinsic to the way Hoxa1 interacts with pathways, needing only one or few direct contacts. To account for the latter possibility, we also analyzed second-degree interactors, proteins that interact with Hoxa1 targets. Proteins associated with 21 pathways are overrepresented compared to random expectation (Table [4](#T4){ref-type="table"}), showing that Hoxa1 could play a role in various processes other than gene regulation, such as focal adhesion, axon guidance or several signaling cascades.

###### 

Pathways enriched in secondary Hoxa1 interactors

  **Pathway name**                                              **ID\***   **Obs**^**\$**^   **Odds ratio**^**£**^   **FDR**^**μ**^   **Corr FDR**^**§**^   **Source**   **Gene symbols**                            **Entrez gene IDs**
  ------------------------------------------------------------- ---------- ----------------- ----------------------- ---------------- --------------------- ------------ ------------------------------------------- ----------------------------------------
  RXR and RAR hetrodimerization with other nuclear receptor     pc926      2                 24,83                   2,00E-05         2,40E-03              NCI-Nature   FAM120B,NR1H2                               84498,7376
  Cell adhesion molecules (CAMs) - Homo sapiens (human)         hsa04514   2                 19,70                   9,00E-05         1,35E-02              KEGG         CLDN2,PVRL2                                 9075,5819
  Gap junction - Homo sapiens (human)                           hsa04540   2                 16,59                   8,00E-05         1,20E-02              KEGG         GNAI2,PDGFRB                                2771,5159
  Signaling events mediated by PTP1B                            pc948      4                 12,72                   1,00E-05         1,20E-03              NCI-Nature   CRK,SPRY2,TRPV6,PDGFRB                      1398,10253,55503,5159
  Retinoic acid receptors-mediated signaling                    pc960      3                 10,19                   2,10E-04         2,52E-02              NCI-Nature   NR1H2,NRIP1,FAM120B                         7376,8204,84498
  Integrins in angiogenesis                                     pc989      3                 10,04                   3,40E-04         4,08E-02              NCI-Nature   CDKN1B,SPP1,VCL                             1027,6696,7414
  Down-stream signal transduction                               pc690      2                 8,28                    5,00E-05         3,14E-02              Reactome     PDGFRB,NCK2                                 5159,8440
  Signaling by PDGF                                             pc876      2                 8,28                    5,00E-05         3,14E-02              Reactome     PDGFRB,NCK2                                 5159,8440
  Toll-like receptor signaling pathway - Homo sapiens (human)   hsa04620   3                 7,54                    3,20E-04         4,80E-02              KEGG         TRAF6,TOLLIP,SPP1                           7189,54472,6696
  Homologous recombination - Homo sapiens (human)               hsa03440   2                 7,18                    1,40E-04         2,10E-02              KEGG         TOP3B,RAD54B                                8940,25788
  LPA receptor mediated events                                  pc1042     4                 7,07                    1,30E-04         1,56E-02              NCI-Nature   BIRC2,TRIP6,TRAF6,CRK                       329,7205,7189,1398
  Focal adhesion - Homo sapiens (human)                         hsa04510   8                 6,55                    3,00E-05         4,50E-03              KEGG         SPP1,VCL,VASP,CRK,PDGFRB,BIRC2,CCND3,PAK7   6696,7414,7408,1398,5159,329,896,57144
  TCR signaling in naive CD4+ T cells                           pc1031     4                 6,54                    3,00E-04         3,60E-02              NCI-Nature   BIRC2,TRAF6,GRAP2,TRPV6                     329,7189,9402,55503
  Axon guidance - Homo sapiens (human)                          hsa04360   5                 6,50                    1,40E-04         2,10E-02              KEGG         GNAI2,PAK7,NTN4,ABLIM1,NCK2                 2771,57144,59277,3983,8440
  TCR signaling in naive CD8+ T cells                           pc997      4                 6,34                    3,80E-04         4,56E-02              NCI-Nature   TRAF6,GRAP2,TRPV6,BIRC2                     7189,9402,55503,329
  Lysine degradation - Homo sapiens (human)                     hsa00310   3                 6,28                    1,00E-04         1,50E-02              KEGG         OGDH,AASDHPPT,EHMT2                         4967,60496,10919
  IGF1 pathway                                                  pc1041     3                 6,26                    3,60E-04         4,32E-02              NCI-Nature   CRK,NCK2,YWHAE                              1398,8440,7531
  p75(NTR)-mediated signaling                                   pc978      5                 6,02                    2,60E-04         3,12E-02              NCI-Nature   YWHAE,TRAF6,BIRC2,RTN4,LINGO1               7531,7189,329,57142,84894
  Proteogylcan syndecan-mediated signaling events               pc1045     5                 5,53                    2,20E-04         2,64E-02              NCI-Nature   BSG,HGS,CRK,SPRY2,SPP1                      682,9146,1398,10253,6696
  Syndecan-1-mediated signaling events                          pc974      3                 5,46                    1,60E-04         1,92E-02              NCI-Nature   BSG,CRK,HGS                                 682,1398,9146
  Plasma membrane estrogen receptor signaling                   pc1048     6                 4,07                    3,60E-04         4,32E-02              NCI-Nature   CRK,SLC9A1,IRF4,NCK2,YWHAE,TRAF6            1398,6548,3662,8440,7531,7189

\* pathway identifier.

\$ number of Hoxa1 interactors belonging to the corresponding pathway.

^£^ the odds ratio represents the enrichment of the corresponding pathway, an odds ratio of 10 meaning that the considered pathway is observed 10 times more than expected at random.

^μ^false discovery rate as computed through the simulation.

^§^corrected false discovery rate accounting for multiple testing.

Hoxa1-mediated interactions take place in distinct cell compartments
--------------------------------------------------------------------

We tested the 45 validated Hoxa1 interacting proteins by Bimolecular Fluorescence Complementation (BiFC) assay, which not only tests for protein interactions but can also visualize where the distinct interactions occur in live cells. For BiFC, the ORF corresponding to each interactor was fused C-terminally to the N-terminal 173 amino acids of the Venus fluorescent protein (VN173), while the Hoxa1 ORF was fused downstream of the C-terminal moiety of Venus (amino acids 155 to 243; VC155). Detectable fluorescence in cells transfected for the complementary VN173 and VC155 fusion proteins means that a functional Venus has been reconstituted, indicating that the partner proteins interact. As a preliminary control, BiFC was assayed for the well-established Hoxa1-PBX1A interaction (Figure [2](#F2){ref-type="fig"}). The VN173-PBX1A and VC155-Hoxa1 fusion proteins provided fluorescence complementation (Figure [2](#F2){ref-type="fig"}A), whereas the VN173-PBX1A/VC155 and VN173/VC155-Hoxa1 combinations did not (Figure [2](#F2){ref-type="fig"}B, C). This therefore supported that the N- and C-terminal Venus fragments did not reassociate if not fused to interacting proteins. In addition, the immunocytolocalization of Venus consistently revealed that the VN173- and VC155-containing fusion proteins displayed a broad intracellular distribution that completely encompassed the narrower BiFC signal. In agreement with these controls, like the VN173-PBX1A fusion (Figure [2](#F2){ref-type="fig"}B), none of the VN173-interactor fusions provided fluorescence alone or in the presence of the VC155 Venus fragment alone (data not shown). For 41 out of the 45 interactors tested specific fluorescence was observed upon addition of the VC155-Hoxa1 fusion protein. Distinct patterns of intracellular interactions were observed (see Table [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}, Figure [3](#F3){ref-type="fig"}). For 31 proteins, interactions took place in the nucleus (Figure [3](#F3){ref-type="fig"}A and C). Of these, 16 proteins appeared to contact Hoxa1 exclusively in the nucleus, while 15 also displayed other patterns of subcellular fluorescence complementation. Among the proteins found to bind Hoxa1 in the nucleus, some were known transcription factors (Table [5](#T5){ref-type="table"}) or were known to have nuclear functions, but other were not (e.g. LGALS13, LIMS1, LNX2, MGAT5B, RBPMS, RAB33A, RGS20, TSCR1). A set of proteins shared a similar interaction pattern characterized by a diffuse, finely-punctuated cytoplasmic signal without nuclear staining (Figure [3](#F3){ref-type="fig"}B). This subcellular localization pattern was observed for different proteins reported to participate in a common signaling pathway. Examples are TRAF, TRIP or PDCD6IP (also known as Alix) which are found associated with the TNFR family of receptors \[[@B36]-[@B41]\], SPRY1 and PDCD6IP modulating RTK downstream signaling \[[@B42]-[@B46]\], PDLIM7 (alias LMP1) and RBPMS (also known as Hermes) which are involved in the BMP/TGFβ signaling regulation \[[@B47],[@B48]\] and LPXN, PDCD6IP and TRIP6 known to associate with focal adhesion sites and related signal transduction \[[@B49]-[@B53]\]. As a control, in cells co-expressing GST-TRAF1 fusion and wildtype Hoxa1, proteins displayed an overlapping intracellular distribution consistent with the BiFC signal observed with VN173-TRAF1/VC155-Hoxa1 (Figure [4](#F4){ref-type="fig"}). Fourteen interactors tested displayed variable interaction patterns, showing mostly nuclear to nuclear and cytoplasmic or nuclear and vesicular BiFC signal (Figure [3](#F3){ref-type="fig"}A and C). This heterogeneous distribution suggests a coordinated shuttling between cell compartments for Hoxa1 and some partners (e.g. MDFI, OGT, PITX2, PRDM14, RBCK1, RBPMS, SPRY1, ZBTB16). The specific associations between Hoxa1 and 41 interactors detected by BiFC shows that Hoxa1 can associate dynamically with distinct categories of proteins in distinct intracellular domains.

![**Bimolecular Fluorescence Complementation assay reveals the Hoxa1-PBX1A interaction in culture cells.** COS7 cells were transfected with combinations of VN173, VN173-PBX1A, VC155 and VC155-Hoxa1 expression vectors. Upon interaction between PBX1A and Hoxa1, the VN173 and VC155 moieties of the Venus fluorescent protein brought together provide a fluorescent signal (**A**). Fluorescence complementation does not appear when the VN173 or VC155 fragments are expressed instead of the corresponding fusion proteins (**B**-**C**). As a control, expression of Venus fragments is detected by immunocytochemistry (anti-GFP). The BiFC signal shows colocalization with the anti-GFP immunofluorescence (**D**-**F**).](1471-213X-12-29-2){#F2}

![**Bimolecular Fluorescence Complementation assay reveals the Hoxa1-mediated interactions in culture cells.** MCF10A cells were transfected with VN173-hORF and VC155-Hoxa1 fusion proteins. Upon interaction between the partner proteins, the VN173 and VC155 moieties of the Venus fluorescent protein brought together provide a fluorescent signal. The interactions between Hoxa1 and its interactors can be classified according to their intracellular pattern: (**A**) nuclear, (**B**) cytoplasmic or associated to vesicles, (**C**) nuclear and cytoplasmic and/or vesicular.](1471-213X-12-29-3){#F3}

###### 

Functional classification of Hoxa1 interactors

  **Function**                   **Interactor**   **Function**                          **Interactor**
  ------------------------------ ---------------- ------------------------------------- ----------------
  **Cell shape and migration**                    **Signal transduction** (continued)   
  Focal adhesion associated      LIMS1 (PINCH1)   Other                                 MDFI
                                 LPXN                                                   PDLMI7 (LMP-1)
                                 MGAT5B                                                 PLZF
                                 PDCD6IP (Alix)                                         SMOC1
                                 TRIP6                                                   
  Cytoskeleton binding           FHL5 (ACT)       **Vesicular trafficking**             PDCD6IP
                                 LPXN                                                   Rab33A
                                 PDCD6IP (Alix)                                         SPRY2
                                 TRIP6                                                  TRAPPC6A
  Cell junctions dynamics        LNX-2                                                  TRIM23 (ARD1)
  **Signal transduction**                         **Transcription regulation**          FHL5 (ACT)
                                                                                        GRN precursor
  BMP/TGFb                       PDLIM7 (LMP-1)                                         HOXA1
                                 RBPMS (Hermes)                                         HOXD3
  Growth factors/RTK             LIMS1 (PINCH1)                                         HSFY1
                                 PDCD6IP (Alix)                                         IKZF2 (Helios)
                                 PLSCR1                                                 LPXN
                                 SPRY2                                                  MDFI (I-mfa)
                                 SPRY1                                                  N4BP2L2
  TNFR family                    PDCD6IP (Alix)                                         OGT
                                 RBCK1                                                  PITX2
                                 TRAF1                                                  PLSCR
                                 TRAF2                                                  PRDM14
                                 TRIM23 (ARD1)                                          RBCK1
                                 TRIP6                                                  TRAPPC6A
  Wnt/b-catenin                  MDFI                                                   TRIP6
  Focal adhesion/integrin        LIMS1 (PINCH1)                                         ZBTB16 (PLZF)
                                 LPXN                                                   ZBTB32 (FAZF)
                                 PDCD6IP (Alix)                                         ZZZ3
                                 TRIP6                                                   
  Notch                          LNX-2            **Secreted protein/ECM**              EFEMP2
  Protein kinases                LGALS13                                                GRN
                                 MDFI                                                   PDCD6IP
                                 PLSCR1                                                 SMOC1
                                 RBCK1                                                   
                                 RGS20            **Miscellaneous**                     KRT81
                                 SPRY2                                                  KRTAP
                                 TRIP6                                                  PLSCR
  GPCR                           RGS20                                                  PLZF
                                 ZBTB16 (PLZF)                                          RAB33A
                                                                                        RBPMS

![**Hoxa1 and TRAF1 intracellular distributions overlap.** MCF10A cells were transfected with GST-TRAF1 and Hoxa1 expression vectors. The immunolocalization of GST-TRAF1 and Hoxa1 (anti-GST, anti-TRAF1 and anti-Hoxa1 immunocytofluorescence) reveals that the partner proteins display partially overlapping intracellular distribution.](1471-213X-12-29-4){#F4}

Discussion
==========

By a high-throughput Y2H screen we identified 59 Hoxa1 interacting proteins among which 45 were confirmed by co-precipitation from animal cells. The intracellular localization of 41 interactions was further detected by a BiFC approach. This is the first exhaustive screen and analysis for interactors of a Hox protein. Our data support the conclusion that Hox proteins, and Hoxa1 in particular, known as crucial transcription factors controlling developmental processes can fulfill unexplored roles in cell signaling, cell adhesion, or vesicular trafficking.

Hoxa1 appears to interact with several proteins found to be part of molecular platforms associated with a few signaling pathways (TNFR superfamily, RTK, BMP/TGFβ, Focal adhesion,...), membrane dynamics and vesicular trafficking (Table [5](#T5){ref-type="table"}). These platforms contact activated receptors at the plasma membrane and can positively or negatively modulate the downstream signaling or subsequent internalization in the endosomal compartment. By interacting with these proteins Hoxa1 could either act as a modulator or an effector of these signaling pathways. The BiFC assay revealed that most of the interactors involved in signaling pathways display a similar pattern of Hoxa1 interaction in culture cells. LPXN, PDLIM7, PDCD6IP, RBPMS, SPRY1, TRAF1, TRAF2 and TRIP6, for example, showed a BiFC signal in the cytoplasm, with fine punctuated staining probably related to vesicular compartments (Figure [2](#F2){ref-type="fig"}B). Although further experiments are required to identify these compartments, our data suggest that Hoxa1 interacts with distinct modulators of a given pathway at the level of shared molecular platforms. Finally, some interactors such as MDFI, OGT, RBCK1, RBPMS or SPRY1 display various patterns of Hoxa1 interaction from cell to cell, possibly indicating dynamic partnerships depending on cell physiological state (Figure [3](#F3){ref-type="fig"}A and C).

Some links might be drawn between the molecular, cellular and developmental processes involving Hoxa1 and its interactors. LIMS1 for example is expressed in neural crest cells and plays an important role in neural crest development through TGFβ signaling \[[@B54]\]; in mouse, a downregulation of SPRY1 inhibits the rhombomere4-derived neural crest cells to colonize the 2^nd^ branchial arch \[[@B55]\]; RBPMS is expressed in the outflow tract of the developing heart \[[@B56]\], a territory colonized by Hoxa1 positive cells \[[@B57]\]. An important group of interactors consists in transcription factors. Some of them are known to be involved in embryonic patterning or cell fate decision (HOXD3, MDFI, PITX2 for example). In that regard, ZBTB16 (better known as PLZF) is a particularly relevant Hoxa1 interactor. It is expressed during hindbrain development at rhombomere boundaries and, like Hoxa1, has been proposed to control hindbrain segmentation \[[@B58]\]. Transcriptional coregulators, like the SET-domain histone methyl-transferase PRDM14 or the O-linked-N-acetyl-glucosamine (GlcNac) transferase OGT, have also been identified as Hoxa1 interactors which may contribute to Hoxa1-mediated gene regulation. Most significantly, OGT has recently been shown to be the homologue of the Drosophila Super sex combs (Sxc) protein. Sxc is associated to Polycomb complexes and is required for their ability to repress gene expression, including *Hox* genes \[[@B59]\].

Conclusions
===========

We presented here the first large-scale Hox interactome characterized so far. Although only a handful of interactors are known for other Hox proteins, some interactors identified here for Hoxa1 are shared with other Hox proteins \[[@B28]\]. PLSCR1 has been shown to contact HOXA9 and HOXB6, and HOXA9 is also contacted by TRIP6. RBPMS is able to interact with HOXA9 and HOXB9. These interactions, as well as other described here, underline that Hox proteins should be viewed not only as gene regulators, but also as components of signal transduction and modulation of cell-to-cell communication, cell adhesion and vesicular trafficking.

Methods
=======

Yeast two-hybrid screening
--------------------------

The mouse *Hoxa1* coding sequence was amplified from the pGIH327 expression plasmid\[[@B60]\] and cloned into pDONR-223 by Gateway BP recombinational reaction (*att*B1.1 primer: *GGGGACAACTTTGTACAAAAAAGTTGGCATG*AACTCCTTTCTGG; *att*B2.1 primer: *GGGGACAACTTTGTACAAGAAAGTTGGGTA*GTGGGAGGTAGTCAGAGTGTC; Invitrogen). By Gateway LR recombinational cloning, *Hoxa1* was then transferred into pDEST-DB and pDEST-AD-CYH2 centromeric destination vectors \[[@B29]\] to code for Gal4 DNA binding domain (DB)-Hoxa1 and Gal4 activation domain (AD)-Hoxa1 fusion proteins, respectively.

*MAT***α** Y8930 and *MAT***a** Y8800 yeast strains (genotype: *trp1-901; leu2-3, 112; ura3-52; his3-200; gal4Δ; gal80Δ; GAL2-ADE2; LYS2::GAL1-HIS3; met2::GAL7-lacZ; cyh2*^*R*^) were used for yeast two-hybrid (Y2H) screens. The DB-Hoxa1 coding construct was first tested for auto-activation by transforming it into the *MAT***α** Y8930 yeast strain and testing for expression of the *HIS3* reporter gene in the absence of any AD-hORF fusion protein, on a solid synthetic complete medium lacking leucine and histidine (Sc-L-H) and supplemented with 1mM 3-amino-triazol (3AT) \[[@B29]\]. The DB-Hoxa1 construct did not auto-activate.

High-throughput Y2H screens were essentially performed as described \[[@B29]\]. Briefly, DB-Hoxa1 and AD-Hoxa1 vectors were transformed into *MAT***α** Y8930 or *MAT***a** Y8800 yeast strains, respectively. The DB-Hoxa1 construct in *MAT***α** Y8930 was mated with *MAT***a** Y8800 containing the AD-hORF library \[[@B27]\], and for the other configuration DB-hORFs library in *MAT***α** Y8930 were mated with AD-Hoxa1 in *MAT***a** Y8800. After overnight growth at 30°C, diploid yeast cells were transferred to plates lacking histidine, leucine and tryptophan, supplemented with 1mM 3AT (Sc-L-T-H+3AT), to select for those with elevated expression of the *GAL1-HIS3* reporter gene.

Positive colonies were picked, grown on Sc-L-T plates, and retested on Sc-L-T-H, as well as on medium lacking Adenine (Sc-L-T-A) and Sc-L-T-H-A+3AT, to select for colonies with high *GAL1-HIS3* and *GAL2-ADE2* reporter gene activity. To detect any spontaneous auto-activators arising in the course of the screen, positive colonies were transferred in parallel onto cycloheximide containing media (Sc-H+CHX). Candidate colonies that grew on Sc-H+CHX were discarded.

The identities of candidate interacting pairs was determined by sequencing PCR products amplified directly from yeast cells using primers specific to Gal4DB and Gal4AD (DB primers: *GGCTTCAGTGGAGACTGATATGCCTC*, *GGAGACTTGACCAAACCTC TGGCG*; AD primers: *CGCGTTTGGAATCACTACAGGG*, *GGAGACTTGACCAAACC TCTGGCG*). PCR products were purified (Qiagen kit \# 28104) and sequenced.

The protein interactions from this publication have been submitted to the IMEx (<http://www.imexconsortion.org>) consortium through IntAct \[pmid: 19850723\] and assigned the identifier IM-15418.

Co-precipitation assays
-----------------------

The *Hoxa1* coding sequence was transferred from the pDONR-223 Gateway® vector to pDEST-FLAG mammalian expression vector by Gateway® LR recombination reaction. Open reading frames coding for interactors from the hORFeome were cloned into a pDEST-GST mammalian expression vector by the same procedure.

COS7 and HEK293T cells were maintained in Dulbecco's modified Eagle's medium (DMEM) low glucose or high glucose respectively (Gibco/Invitrogen) supplemented with Glutamine, 10% fetal bovine serum (Gibco/Invitrogen), 100 IU/ml penicillin, and 100 μg/ml streptomycin (Gibco/Invitrogen). Cell lines were maintained at 37°C in a humidified, 5% CO~2~ atmosphere. For transient transfection, 1.4 × 10^5^ (COS7) or 4 × 10^5^ (HEK293T) cells were plated into six-well plates. Twenty-four hours after plating, cells were transfected with TransFectin™ reagent (BioRad). One and a half μg of pDEST-FLAG-Hoxa1 expression vector and 3μg of pDEST-GST-hORF were mixed with 250μl of serum-free medium and added to a mix of 1 μl of TransFectin™ and 250μl of serum-free medium. Forty-eight hours after transfection, cells were lysed with Tris--HCl pH7.5 20mM, NaCl 120mM, EDTA 0.5mM, NP40 0.5%, glycerol 10% and Complete™ protease inhibitor (Roche).

Cell lysates were cleared by centrifugation for 5 minutes at 13,000 g. Cleared lysates were incubated overnight on gluthatione-agarose beads (Sigma \# G4510). Beads were cleared 3 times with the lysis buffer. Beads and third wash samples were then loaded on SDS-PAGE, transferred on nitrocellulose membrane and processed for detection of FLAG tagged proteins with an anti-FLAG M2 antibody (Sigma \# F1804).

Bimolecular Fluorescence Complementation assay (BiFC)
-----------------------------------------------------

pDEST-VN173 and pDEST-VC155 plasmids were obtained by cloning sequences encoding N-terminal residues 1--173 and C-terminal residues 155--243 of the yellow fluorescent protein VENUS, respectively, within the pDEST-v1899-FLAG vector instead of the 5' \[K*pn*I\|H*ind*III\] 3xFLAG-fragment (VN173F primers : *GAGGTACCATGGTGAGCAAGGGCGAGGAGC*, *GGAGAAGCTTCTCGATGTTGTGGCGGATC*; VC155 primers: *AAGGTACCATGGCCGACAAGCAGAAGAACGGC*, *GGAAAAGCTTCGTGGACCGGTGCTTGTACAGC*).

The *Hoxa1* coding sequence was transferred from the pDONR-223 Gateway® vector to pDEST-VC155 mammalian expression vector by Gateway® LR recombination reaction. Open reading frames coding for interactors from the hORFeome were cloned into the pDEST-VN173 mammalian expression vector by the same procedure.

MCF10A cells were maintained at 37°C in a humidified 5% CO~2~ atmosphere, in DMEM-F12+L-glutamine medium (Gibco/Invitrogen) supplemented with 5% horse serum (Gibco/Invitrogen), 100 IU/ml penicillin (Gibco/Invitrogen), 100 μg/ml streptomycin (Gibco/Invitrogen), 100 ng/ml of cholera toxin (Gentaur), 20 ng/ml of human Epidermal Growth Factor (hEGF; Sigma), 500 ng/ml hydroxycortisone (Sigma) and 10 μg/ml insulin (Sigma). For transfection, 3 × 10^5^ cells were seeded on glass cover slips in 24-well plates. Twenty-four hours after plating, cells were transfected with TransFectin™ reagent (BioRad) or JetPRIME (Polyplus). For JetPRIME transfection, a total of 500 ng of plasmid DNA were transfected per well: 100 ng of pDEST-VN173-hORF, 20 ng of pDEST-VC155-Hoxa1 and 380 ng carrier DNA. DNA was mixed with 50 μl JetPRIME buffer and 1 μl of JetPRIME was added further. For TransFectin™-mediated transfection, 500 ng of pDEST-VN173-hORF and 500 ng of pDEST-VC155-Hoxa1 were mixed with 50 μl of serum-free medium and added to a mix of 1 μl of TransFectin™ and 50 μl of serum-free medium. Twenty-four hours after transfection, cells were fixed with 4% formaldehyde for 30 minutes, rinsed three times in PBS and once in TBS-0,1% Triton X100. Glass cover slips were mounted in Vectashield®-DAPI medium (Vector laboratories). BiFC were then analysed by confocal microscopy (LSM710, Zeiss, Jena, Germany; Plan-Apochromat 63x/1.40 Oil DIC M27 objective; Oil refraction index 1.5 imaging medium; PMT camera). Images were acquired by using the ZEN 2010 software, and subsequently processed with ZEN 2008 Light Edition.

Immunocytolocalization
----------------------

COS7 and MCF10A cells were maintained, seeded on coverslips and transfected as described here above. Twenty four hours after transfection, cells were fixed with 4% formaldehyde for 30 minutes. Cells were further blocked with 10% low-fat milk in TBS-0.1% Triton X100 solution for 45 min at room temperature, followed by overnight incubation in TBS-0.1% Triton X100 solution at 4°C, with a rabbit polyclonal anti-GFP (Invitrogen A11122, diluted 1/200), a mouse anti-GST (Sigma G1160, diluted 1/50), a mouse monoclonal anti-TRAF1 (Santa Cruz, sc-6253, diluted 1/50), or a rabbit polyclonal anti-Hoxa1 (Abcam ab64941, diluted 1/50), as primary antibodies. Cells were rinsed three times for 30 min in TBS-0.1% Triton X100 solution and incubated for 45 min at room temperature with a goat anti-rabbit IgG-AF555 (Molecular Probes 4413, diluted 1/750), a goat anti-mouse IgG-FITC (SantaCruz sc-3699, diluted 1/100), or a bovine anti-rabbit IgG-TRITC (SantaCruz sc-2367, diluted 1/100), as secondary antibodies. Cells were rinsed three times and glass cover slips were mounted in Vectashield®-DAPI medium (Vector laboratories). Slides were then analysed by confocal microscopy (LSM710, Zeiss, Jena, Germany; Plan-Apochromat 63x/1.40 Oil DIC M27 objective; Oil refraction index 1.5 imaging medium; PMT camera). Images were acquired by using the ZEN 2010 software, and subsequently processed with ZEN 2008 Light Edition.

Gene Ontology annotation and pathway analysis
---------------------------------------------

Gene Ontology (GO) annotations were downloaded from Entrez Gene (September 2009), pathway data from KEGG (September 2008) and Pathway Commons (September 2008) databases. From Pathway Commons, we analyzed the pathways originally annotated in NCI-Nature\[pid.nci.nih.gov\] and Reactome \[[@B61]\].

Fisher's Exact Test was used to determine GO annotation and pathway enrichment of Hoxa1 direct targets, using the space of human proteins that have been tested in our Y2H experiment, the human ORFeome v3.1 \[[@B27]\]. The corrected *p*-value was computed using the Benjamini-Hochberg multiple testing correction. We limited our results to GO annotations and pathways for which at least two Hoxa1 targets were annotated for.

To estimate the significance of indirect targets enrichment we ran 100,000 simulations for which the identity of the direct targets was randomized. The interactors of these targets were identified in an unbiased protein-protein interaction network \[[@B28]\], to avoid study bias inherent to literature curation. Interactors belonging to each pathway were counted, and the resulting distribution compared to the observed counts. An empirical False Discovery Rate (FDR) determined the significance of the enrichment, with the FDR computed as the proportion of random trials giving at least the observed number of indirect targets in the analyzed pathway. The FDR was corrected for multiple testing using the Bonferroni correction. Pathways with a corrected FDR \< 0.05 and at least two observed proteins were considered significant.
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